Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01016522
What this trial is testing

Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Johns Hopkins University 1
Large-scale testing (Phase 3)Not Yet RecruitingNCT07325591
What this trial is testing

Efficacy and Safety of Tazbentetol in ALS Participants

Who this might be right for
Amyotrophic Lateral Sclerosis
Spinogenix 430
Testing effectiveness (Phase 2)Study completedNCT03482050
What this trial is testing

Evaluate Transplantation of Astrocytes Derived From Human Embryonic Stem Cells, in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Kadimastem 16
Large-scale testing (Phase 3)Study completedNCT00965497
What this trial is testing

Escitalopram (Lexapro) for Depression MS or ALS

Who this might be right for
Major DepressionMultiple SclerosisAmyotrophic Lateral Sclerosis
University of South Carolina 13
Large-scale testing (Phase 3)Study completedNCT04615923
What this trial is testing

HEALEY ALS Platform Trial - Regimen D Pridopidine

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 163
Not applicableStudy completedNCT03706391
What this trial is testing

Study of ALS Reversals 4: LifeTime Exposures

Who this might be right for
Amyotrophic Lateral SclerosisProgressive Muscular AtrophyMotor Neuron Disease
Duke University 25
Testing effectiveness (Phase 2)Study completedNCT00326625
What this trial is testing

Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Teva Pharmaceutical Industries, Ltd. 366
Not applicableLooking for participantsNCT06877143
What this trial is testing

Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
University of Ulm 76
Early research (Phase 1)Study completedNCT03626012
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Biogen 106
Post-approval studies (Phase 4)Study completedNCT00542412
What this trial is testing

CARE Canadian ALS Riluzole Evaluation

Who this might be right for
Amyotrophic Lateral Sclerosis
Sanofi 414
Testing effectiveness (Phase 2)Study completedNCT00748501
What this trial is testing

Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Sangamo Therapeutics 45
Very early researchNot Yet RecruitingNCT07080801
What this trial is testing

Study on the Safety and Efficacy of RAG-21 in the Treatment of Amyotrophic Lateral Sclerosis Patients With FUS Gene Mutations

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Beijing Tiantan Hospital 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07169175
What this trial is testing

A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
SineuGene Therapeutics Co., Ltd. 21
Not applicableLooking for participantsNCT07235111
What this trial is testing

Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases

Who this might be right for
Alzheimer DiseaseFTDYoung-onset Dementia+3 more
Ospedale Policlinico San Martino 1,200
Testing effectiveness (Phase 2)Ended earlyNCT00160004
What this trial is testing

The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Radboud University Medical Center 20
Testing effectiveness (Phase 2)WithdrawnNCT01984814
What this trial is testing

Stem Cell Therapy for Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Neurogen Brain and Spine Institute
Not applicableStudy completedNCT01964664
What this trial is testing

Mindfulness Meditation for Subjects With Severe Speech and Physical Impairments

Who this might be right for
Physical ImpairmentsCerebral PalsyCerebral Ataxia+1 more
Oregon Health and Science University 8
Not applicableUnknownNCT04952038
What this trial is testing

Sleep Disorders and the Onset and Progression of ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 200
Not applicableTemporarily Not AvailableNCT00596115
What this trial is testing

Treating Amyotrophic Lateral Sclerosis (ALS) With R(+) Pramipexole Dihydrochloride Monohydrate at 60 mg/Day

Who this might be right for
Amyotrophic Lateral Sclerosis
Bennett, James P., Jr., M.D., Ph.D.
Not applicableEnrolling By InvitationNCT04961450
What this trial is testing

Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal DementiaMotor Neuron Disease
Peking University Third Hospital 2,500
Next Page